278 related articles for article (PubMed ID: 16142877)
1. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
Hartgring SA; Willis CR; Alcorn D; Nelson LJ; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Sep; 62(9):2716-25. PubMed ID: 20499386
[TBL] [Abstract][Full Text] [Related]
4. Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo.
Suzaki H; Asano K; Ohki S; Kanai K; Mizutani T; Hisamitsu T
Mediators Inflamm; 1999; 8(4-5):199-204. PubMed ID: 10704073
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory action of roxithromycin on tumour necrosis factor-alpha production from mast cells in vitro.
Shimane T; Asano K; Mizutani T; Suzaki H
In Vivo; 1999; 13(6):503-6. PubMed ID: 10757045
[TBL] [Abstract][Full Text] [Related]
6. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
Shimane T; Asano K; Suzuki M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2001 Dec; 10(6):323-32. PubMed ID: 11817673
[TBL] [Abstract][Full Text] [Related]
7. Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.
You X; Pan M; Gao W; Shiah HS; Tao J; Zhang D; Koumpouras F; Wang S; Zhao H; Madri JA; Baker D; Cheng YC; Yin Z
Arthritis Rheum; 2006 Mar; 54(3):877-86. PubMed ID: 16508970
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
Lee YC; Kim SH; Roh SS; Choi HY; Seo YB
J Ethnopharmacol; 2007 May; 112(1):40-8. PubMed ID: 17353105
[TBL] [Abstract][Full Text] [Related]
9. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
[TBL] [Abstract][Full Text] [Related]
10. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
12. Treatment of collagen-induced arthritis by Natura-alpha via regulation of Th-1/Th-17 responses.
Glatigny S; Blaton MA; Mencher SK; Mistou S; Lucas B; Fournier C; Wang LG; Chiocchia G
Eur J Immunol; 2010 Feb; 40(2):460-9. PubMed ID: 20077403
[TBL] [Abstract][Full Text] [Related]
13. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
14. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis.
Nozaki Y; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M
Clin Immunol; 2006 Jun; 119(3):272-9. PubMed ID: 16412693
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
[TBL] [Abstract][Full Text] [Related]
18. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
Munakata Y; Iwata S; Dobers J; Ishii T; Nori M; Tanaka H; Morimoto C
Arthritis Rheum; 2000 Jul; 43(7):1616-23. PubMed ID: 10902767
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
[TBL] [Abstract][Full Text] [Related]
20. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
Chen J; Zhang XM; Xu Q
Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
